Who’s to blame for America’s drug pricing crisis? It’s election year, and a prominent jewel in America’s economic crown—its pharma industry—is a front-and-center attraction. Only, it’s less of a jewel,…
Part 1: An Unwelcome Revelation Let me tell you about Marcus. Marcus was tired. The good kind of tired. He leaned back and stared at the messy flowcharts sprawled across…
In the first instalment of our Ask Me Anything series, Jeffrey Hirono, Global Head of Insight at Impatient Health, speaks to us about the importance of qualitative data and building trust, in overcoming the challenges that face patient engagement today.
Remember that Khloe Kardashian tweet that put tiny Biohaven’s migraine drug on the map in 2020? It culminated in Pfizer’s $11.6 billion Biohaven buyout last month. Digital channels gifted smaller…
When car designers want to test an idea, they don’t just create focus groups. They don’t stop at market research. They take a much bigger step. The concept car has…
Predictions are a waste of time. They’re arrogant. They’re almost always wrong. You might think that’s a strange thing to say when I’ve just had a good response to my…